Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00006982-200412000-00020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of analgesia and akinesia between sub-Tenon's capsule anesthesia and trans-Tenon's capsule retrobulbar anesthesia in vitrectomy.
Fujita Med J
November 2020
Department of Ophthalmology, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Objectives: We compared the effects of sub-Tenon's capsule anesthesia (STA) and trans-Tenon's capsule retrobulbar anesthesia (TTRBA) in 68 patients with epiretinal membrane.
Methods: Either STA or TTRBA was induced with 3 mL of lidocaine (2%) before vitrectomy combined with phacoemulsification and aspiration (phacovitrectomy). Akinesia was evaluated by range of eye movement (ROEM) in upward, downward, nasal, and temporal directions at 4, 10, and 30 minutes after injection.
Retrobulbar triamcinolone for inflammatory choroidal neovascularization in pregnancy.
BMC Ophthalmol
December 2020
IRCCS Sacro Cuore Don Calabria Hospital, Via Don Sempreboni 5 - Negrar, 37024, Verona, Italy.
Background: Choroidal neovascularization (CNV) in pregnancy has rarely been described. A differential diagnosis between inflammatory, idiopathic, and myopic CNV may be challenging. Moreover, there is no consensus on management, and therapeutic options may be further limited by patient and physician concerns about potential risk to the fetus.
View Article and Find Full Text PDF[Use of intravitreal bevacizumab for macular edema in branch retinal vein occlusion].
Nippon Ganka Gakkai Zasshi
June 2009
Eguchi Eye Hospital, Japan.
Purpose: To study the effect of intravitreal bevacizumab on macular edema secondary to branch retinal vein occlusion (BRVO).
Subjects And Methods: 6 eyes of 5 patients averaging 70 years, who had received either retinal photocoagulation or trans-tenon retrobulbar triamcinolone injections or both, but in whom the macular edema remained. There was an average of 337 days from BRVO onset to injection of bevacizumab.
Trans-Tenon's retrobulbar triamcinolone acetonide injection for macular oedema related to branch retinal vein occlusion.
Br J Ophthalmol
January 2008
Department of Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan.
Background: The aim of the study was to evaluate the safety and effectiveness of trans-Tenon's retrobulbar triamcinolone acetonide (TA) injection for macular oedema associated with branch retinal vein occlusion (BRVO).
Methods: We reviewed the medical records of 50 consecutive patients with macular oedema associated with BRVO who were treated with trans-Tenon's retrobulbar TA injection (20 mg) as initial treatment for a follow-up period of at least 12 months. Foveal thickness determined by optical coherence tomography, visual acuity, intraocular pressure (IOP) and cataract progression were measured.
Trans-Tenon's retrobulbar triamcinolone infusion for myopic choroidal neovascularization.
Acta Ophthalmol Scand
December 2006
Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.
Purpose: To report the effects of trans-Tenon's retrobulbar injection of triamcinolone acetonide for subfoveal and juxtafoveal choroidal neovascularization (CNV) caused by pathological myopia.
Methods: Eleven consecutive patients (11 eyes) with myopic CNV were treated with trans-Tenon's retrobulbar injection of triamcinolone acetonide. Each patient received a single injection.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!